ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,064.71
0.58%
Dow Jones
38,187.97
0.98%
US Dollar vs MXN
16.99935
-0.89%
Brent Oil
83.475
-2.82%
Bitcoin
58,462.13
-3.53%
Registration Strip Icon for discussion Regístrate para interactuar en nuestros foros activos para discutir con inversores de ideas afines.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NASDAQ
  6. Keryx Biopharmaceuticals, Inc. (delisted) (KERX)

  7. Keryx Biopharmaceuticals, Inc. (delisted) (KERX) Noticias

KERX

Keryx Biopharmaceuticals, Inc. (delisted) (KERX)

Keryx Biopharmaceuticals, Inc. (delisted)
Fecha:
Ordernar por:
 Showing the most relevant articles for your search:NASDAQ:KERX
FechaHoraFuenteTítuloSímboloCompañía
26/12/201807:01Edgar (US Regulatory)Termination of Registration of a Class of Security Under Section 12(g) (15-12g)NASDAQ:KERXKeryx Biopharmaceuticals, Inc. (delisted)
26/12/201805:02Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:KERXKeryx Biopharmaceuticals, Inc. (delisted)
13/12/201815:42Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:KERXKeryx Biopharmaceuticals, Inc. (delisted)
13/12/201814:54Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:KERXKeryx Biopharmaceuticals, Inc. (delisted)
13/12/201808:20Edgar (US Regulatory)Post-effective Amendment to Proposed Securities Act Rule 462(b) Registration Statement (pos462b)NASDAQ:KERXKeryx Biopharmaceuticals, Inc. (delisted)
13/12/201808:09Edgar (US Regulatory)Post-effective Amendment to an Automatic Shelf Registration of Form S-3asr or Form F-3asr (posasr)NASDAQ:KERXKeryx Biopharmaceuticals, Inc. (delisted)
13/12/201807:25Edgar (US Regulatory)Post-effective Amendment to Registration Statement (pos Am)NASDAQ:KERXKeryx Biopharmaceuticals, Inc. (delisted)
13/12/201806:49Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:KERXKeryx Biopharmaceuticals, Inc. (delisted)
13/12/201806:21Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:KERXKeryx Biopharmaceuticals, Inc. (delisted)
12/12/201815:42Edgar (US Regulatory)Notification Filed by National Security Exchange to Report the Removal From Listing and Registration of Matured, Redeemed or ...NASDAQ:KERXKeryx Biopharmaceuticals, Inc. (delisted)
11/12/201811:00GlobeNewswire Inc.Keryx Biopharmaceuticals Stockholders Approve Merger with Akebia TherapeuticsNASDAQ:KERXKeryx Biopharmaceuticals, Inc. (delisted)
03/12/201815:09Edgar (US Regulatory)Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)NASDAQ:KERXKeryx Biopharmaceuticals, Inc. (delisted)
30/11/201807:55GlobeNewswire Inc.Glass Lewis Recommends that Keryx Biopharmaceuticals Stockholders Vote “FOR” the Proposed Merger with Akebia Therapeutics...NASDAQ:KERXKeryx Biopharmaceuticals, Inc. (delisted)
29/11/201806:00GlobeNewswire Inc.ISS Recommends that Keryx Biopharmaceuticals Stockholders Vote “FOR” the Proposed Merger with Akebia TherapeuticsNASDAQ:KERXKeryx Biopharmaceuticals, Inc. (delisted)
15/11/201816:15Business WireAkebia Therapeutics and Keryx Biopharmaceuticals Announce Chairperson for Combined CompanyNASDAQ:KERXKeryx Biopharmaceuticals, Inc. (delisted)
13/11/201805:07Edgar (US Regulatory)Amended Quarterly Report (10-q/a)NASDAQ:KERXKeryx Biopharmaceuticals, Inc. (delisted)
08/11/201815:30GlobeNewswire Inc.Keryx Biopharmaceuticals Announces Third Quarter 2018 Financial ResultsNASDAQ:KERXKeryx Biopharmaceuticals, Inc. (delisted)
06/11/201815:30GlobeNewswire Inc.Keryx Biopharmaceuticals to Release Third Quarter 2018 Financial Results on Thursday, November 8, 2018NASDAQ:KERXKeryx Biopharmaceuticals, Inc. (delisted)
30/10/201816:31GlobeNewswire Inc.Keryx Biopharmaceuticals Announces Filing of Definitive Joint Proxy Statement in Connection with Pending Merger with Akebia T...NASDAQ:KERXKeryx Biopharmaceuticals, Inc. (delisted)
30/10/201816:28Edgar (US Regulatory)Proxy Statement - Merger or Acquistion (definitive) (defm14a)NASDAQ:KERXKeryx Biopharmaceuticals, Inc. (delisted)
01/10/201808:16GlobeNewswire Inc.Keryx Biopharmaceuticals Announces Participation in an Upcoming Investor ConferenceNASDAQ:KERXKeryx Biopharmaceuticals, Inc. (delisted)
24/09/201814:31Edgar (US Regulatory)Confidential Treatment Order (ct Order)NASDAQ:KERXKeryx Biopharmaceuticals, Inc. (delisted)
09/08/201815:21Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:KERXKeryx Biopharmaceuticals, Inc. (delisted)
08/08/201806:00GlobeNewswire Inc.Keryx Biopharmaceuticals Announces Second Quarter 2018 Financial Results   NASDAQ:KERXKeryx Biopharmaceuticals, Inc. (delisted)
02/08/201815:05GlobeNewswire Inc.Keryx Biopharmaceuticals to Host Conference Call of Second Quarter 2018 Financial Results on Wednesday, August 8, 2018NASDAQ:KERXKeryx Biopharmaceuticals, Inc. (delisted)
29/06/201818:12PR Newswire (US)WeissLaw LLP Investigates Keryx Biopharmaceuticals Inc.NASDAQ:KERXKeryx Biopharmaceuticals, Inc. (delisted)
29/06/201815:29Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:KERXKeryx Biopharmaceuticals, Inc. (delisted)
28/06/201806:00Business WireAkebia Therapeutics & Keryx Biopharmaceuticals to Merge, Creating a Fully Integrated Company Focused on the Development & Com...NASDAQ:KERXKeryx Biopharmaceuticals, Inc. (delisted)
20/06/201808:21GlobeNewswire Inc.Keryx Biopharmaceuticals Announces Participation in a Renal Disease Panel at the JMP Securities Life Sciences Conference on T...NASDAQ:KERXKeryx Biopharmaceuticals, Inc. (delisted)
31/05/201815:14Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:KERXKeryx Biopharmaceuticals, Inc. (delisted)
 Showing the most relevant articles for your search:NASDAQ:KERX

Su Consulta Reciente

COIN
SOLUSD
Solana
AMEX
XLV
Health Care Select Sector
NYSE
XOM
Exxon Mobil
NASDAQ
GOOGL
Alphabet
NYSE
DIS
Walt Disney
AMEX
XLE
Energy Select Sector SPDR
NASDAQ
TSLA
Tesla
USOTC
BASFY
BASF (QX)
NYSE
VZ
Verizon Communications
PM
XAUUSD
Gold vs US Dollar
USOTC
ADDYY
Adidas (QX)
AMEX
XLF
Financial Select Sector
COIN
BTCUSD
Bitcoin
CCOM
SILVER
SILVER
NYSE
KO
Coca Cola
CCOM
OILBRENT
Brent Oil
Delayed Upgrade Clock
ADVFN Logo

México
Empresa
Negocios
Popular
Obtener la aplicación

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados